OSE Immunotherapeutics announces latest leukemia data

OSE Immunotherapeutics has presented data on its anti-IL-7 receptor antagonist OSE-127 for the treatment of acute lymphoblastic leukemia.

Related Keywords

Magdeburg ,Sachsen Anhalt ,Germany ,University Medical Center ,Louisiana ,United States ,New Orleans ,American ,Nicolas Poirier ,Denis Scheweead ,Lennart Lenk ,American Society Of Hematology ,University Medical Center Schleswig Holstein ,Christian Albrechts University Kiel ,Department Of Pediatrics ,American Society ,